Breaking News

AZ, Pharmaron in Discovery Pact

By Gil Roth | October 15, 2012

Services team will work out of Beijing lab

AstraZeneca and Pharmaron have formed a multi-year drug discovery partnership to support AZ's global Innovative Medicines Units. Pharmaron will provide AZ with discovery services in the areas of chemistry, drug metabolism and pharmacokinetics (DMPK), and efficacy screening, conducting these services with a team consisting of several hundred scientists in dedicated research laboratories located in its newly opened drug discovery service center in Beijing.

The co-location of screening and chemistry services at a single partner is expected to help AZ scientists drive their drug discovery programs with greater efficiency, according to a Pharmaron statement. Financial details of the deal were not disclosed.

Manos Perros, head of Infection iMed and sponsor of the collaboration for AZ, said, “We are pleased to enter this strategic partnership with Pharmaron which we believe will help us progress projects through our R&D pipeline more efficiently. Pharmaron scientists will be integrated into our project teams and play an important role in helping us fulfill our commitment to delivering meaningful medicines to patients worldwide.”

Dr. Boliang Lou, Pharmaron’s chairman and chief executive officer, said, “We are honored to be a strategic partner in the drug discovery area with AstraZeneca. This partnership is an important milestone for Pharmaron as we are strengthening our capacity in the area of fully integrated services as a highly competitive and global player.”
blog comments powered by Disqus
  • Flexible Manufacturing Strategies

    Kristin Brooks, Contract Pharma||April 4, 2016
    Michael Lehmann of Patheon discusses solutions for pharmaceutical forecasting errors

  • Platinum Press Facility Tour

    Platinum Press Facility Tour

    Kristin Brooks, Contract Pharma||March 23, 2016
    Opens doors to new, 47,000-sq.-ft. packaging facility in Oakland, NJ

  • Biopharma Packaging Equipment Close-up

    Biopharma Packaging Equipment Close-up

    Kristin Brooks, Contract Pharma||March 7, 2016
    Sieghard Schuchmann of OPTIMA discusses biopharma trends impacting packaging equipment, and the latest capabilities

  • Fit-For-Purpose Assay Development in Bioanalysis

    Fit-For-Purpose Assay Development in Bioanalysis

    Franklin Spriggs, Ligand Binding Assay Group Leader; Ashley Brant, Program Manager, AIT Bioscience||January 28, 2016
    The success of bioanalytical studies relies on the selection of the most suitable analytical method but the timeline of method development and types of analyses involved vary greatly.

  • Bringing Transparency and Collaboration to CRO Oversight

    Bringing Transparency and Collaboration to CRO Oversight

    Craig Morgan , goBalto Inc. ||November 17, 2015
    Relationships between sponsors and CROs are getting stronger

  • Getting Real

    Michael Pollock, PPD||November 17, 2015
    Partnering for clinical and real-world evidence studies